GaBI Journal aims to educate and raise trust in safe and cost-effective use of medicines for healthcare professionals.

To achieve this, GaBI Journal publishes high quality, peer reviewed and independent scientific articles on all aspects of generic and biosimilar medicines, including but not limited to the development of formulations, production, testing including equivalence – in vivo and in vitro, model development, regulatory issues, supply chain management, and pharmacoeconomics, through the support of experts who are highly motivated to share their knowledge and professional experience.

In addition, GaBI Journal endeavours to publish regulatory guidelines and legislation in an abbreviated, simplified format as short reports, facilitating an easier and wider understanding of the technical and complicated official documentation.